200 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
and hedging transactions Prohibition on pledging shares and holding them in a margin account Proactively eliminate windfall gain potential No employment … engaging in any speculative or hedging transactions, as we consider it improper and inappropriate to engage in any transactions that hedge or offset
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
, financial advisory, investment management, principal investment, hedging, financing and brokerage activities. For example, certain of the underwriters … as counterparties to certain derivative and hedging arrangements, and actively trade debt and equity securities (or related derivative securities
424B2
obg3eoao
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
04wdi r00x
25 Jan 24
Third party tender offer statement
8:13am
424B5
6k9to 1f77dyjm5fw23
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
8objc1ipnfq75yh0qp63
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
sdz5mb03
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
hu56j
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
pc00b2lw2s4lf qjxs
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
cs4d d315l2kuip
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
SC TO-T
EX-99
8fvuc0mb3gawt s762
17 Jun 22
Third party tender offer statement
4:42pm